Skip to content

Cancers & treatments

News & evidence

Living with cancer

Learn & contribute

Loading

A public, cited, editable map of oncology: technologies, targets, products, companies, institutions, pathways, trials, pairings, roadmaps, and ideas. One page per object, with a plain-language TL;DR on every page.

Work in progress. Every fact on this site is being built and checked in the open and may be incomplete, out of date, or wrong. You must do your own research and verify anything here at its primary source before relying on it. Nothing on this site is medical advice; decisions belong with you and your clinicians.

OnCo is an information resource, not medical advice. Nothing here replaces a conversation with a qualified clinician. Never delay care because of something you read here; in an emergency, call your local emergency services. Terms of use

Explore
Tags
Search
Path finder
For me
Navigator
Biomarker matrix
Calculators
Interactions
Decision aids
irAE guide
Tumour board
Compare
Landscape grid
Rankings
Timeline
Query
Graph explorer
Saved
Body map

Cancers & treatments

News & evidence

Institutions & people

Institutions
Universities
Trial leadership
People
Heroes and heroines
Companies
Startups
Requests for startups
Investors
Company scorecards
Trial sponsors
Manufacturing map
Countries
India deep dive
China deep dive
Cases by country
Funding flows

Living with cancer

For me
The first 60 days
Appointment prep pack
Side effects
Symptom to test
Report reader
Survivorship planner
Second opinion
Financial help
Free in oncology
Paying for care in the US
NHS coverage
Paying for care in India
Coverage rankings
Cutting cancer care costs
Diet, exercise and lifestyle
Supportive care
Complementary and supportive approaches
Hair loss and regrowth
Heroes and heroines

Learn & contribute

Reading paths
About & methodology
Roadmap
Gaps to fill
Completeness
Review queue
Reviewer roster
Contributors
Idea votes
Teaching packs
Weekly issue
Suggest an edit
Open evaluation
Data dictionary
Build on OnCo
Open API
Open data
Open tools
Open source in oncology
GitHub

© 2026 OnCo. Code MIT. The data are free for individual and educational use with the attribution “Data from OnCo (onco.cc)”, under CC BY-NC 4.0. Commercial use must contact us to pay for the data. Commercial licences. Made with heart and soul by Jude Gomila .

About and methodology Corrections Open API Tags Terms of use Privacy policy GitHub

Loading

Home
Cancers
Lung neuroendocrine tumours (typical and atypical carcinoid)
Data

Cancers·Lung neuroendocrine tumours (typical and atypical carcinoid)

DataLung neuroendocrine tumours (typical and atypical carcinoid)

Back to the Lung neuroendocrine tumours hub →46 connected records

Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.

Overview What it is Finding it Treating it Evidence The science Where you are Living with it What is coming Data

Data

Related pages

46

Direct links plus the targets, companies, and technologies of this cancer's products.

Similar pages

not linked directly; found by shared links

Cancer
Hereditary pheochromocytoma and paraganglioma (SDHx, VHL, RET, NF1, MAX and TMEM127)
Shares Somatostatin receptor PET (68Ga/64Cu-DOTATATE), Peptide receptor radionuclide therapy (PRRT), Somatostatin receptor 2, Lutetium-177 dotatate and the tags subtype-page, endocrine.
Cancer
Metastatic pheochromocytoma and paraganglioma
Shares Somatostatin receptor PET (68Ga/64Cu-DOTATATE), Peptide receptor radionuclide therapy (PRRT), Somatostatin receptor 2, Lutetium-177 dotatate and the tags subtype-page, endocrine.
Cancer
Resectable stage I to III non-small-cell lung cancer
Shares Bronchoscopy (EBUS, robotic navigation), Lobectomy, CT (computed tomography), Robotic & minimally invasive surgery and the tags subtype-page, lung.
Cancer
Localised adrenocortical carcinoma (ENSAT stage I to III, resectable)
Shares CT (computed tomography), Robotic & minimally invasive surgery and the tags subtype-page, endocrine.
Cancer
Advanced and metastatic adrenocortical carcinoma (ENSAT stage IV or unresectable)
Shares Cabozantinib and the tags subtype-page, endocrine.
Cancer
Limited-stage small-cell lung cancer
Shares Lobectomy and the tags subtype-page, lung.
Cancer
EGFR-mutated non-small-cell lung cancer
Shares Lobectomy and the tags subtype-page, lung.
Cancer
ALK-positive non-small-cell lung cancer
Shares the tags subtype-page, lung.

technologies

10

Anti-angiogenic therapy CT (computed tomography)Cytotoxic chemotherapy Peptide receptor radionuclide therapy (PRRT)PET/CT PI3K, AKT and mTOR inhibitors Radioligand therapy (beta emitters)Robotic & minimally invasive surgery Small-molecule kinase inhibitors Somatostatin receptor PET (68Ga/64Cu-DOTATATE)

targets

7

AKT MET mTOR PIK3CA / PI3K-alpha RET Somatostatin receptor 2 VEGF / VEGFR

drugs

7

ApprovedSmall-molecule multi-kinase inhibitor (MET, VEGFR2, AXL, RET)

Cabozantinib · Cabometyx

EstablishedOral cytotoxic regimen

Capecitabine + temozolomide (CAPTEM)

ApprovedSmall-molecule mTOR inhibitor

Everolimus · Afinitor

ApprovedPET radiotracer (somatostatin receptor ligand)

Gallium-68 DOTATATE (and Cu-64 DOTATATE) · Netspot / Detectnet

ApprovedRadioligand therapy (beta)

Lutetium-177 dotatate · Lutathera

ApprovedMultireceptor somatostatin analogue (subcutaneous or monthly depot)

Pasireotide · Signifor / Signifor LAR

ApprovedPeptide hormone analogue (SSTR2 agonist)

Somatostatin analogues (octreotide, lanreotide) · Sandostatin LAR, Somatuline Depot

companies

5

Curium Exelixis Ipsen Novartis Recordati

terms

5

Bronchoscopy (EBUS, robotic navigation)Carcinoid syndrome and carcinoid heart disease Chromogranin A Lobectomy Neuroendocrine tumour grade (Ki-67) and WHO classification

trials

6

CABINET (Alliance A021602)CLARINET RADIANT-3 and RADIANT-4 SPINET Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

people

1

Jennifer A. Chan

key papers

3

CABINET (Alliance A021602): cabozantinib for advanced neuroendocrine tumours ENETS expert consensus on pulmonary neuroendocrine (carcinoid) tumours RADIANT-4: everolimus for advanced non-functional neuroendocrine tumours of the lung or gastrointestinal tract

biomarkers

2

Ki-67 index (proliferation by IHC)Somatostatin receptor expression by PET (SSTR-positive)

Machine-readable versions

The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.

JSON with neighbours Markdown context RDF Turtle Sections with routes and counts API root

Not yet reviewedNeeds expert (clinical) and patient advocate review. Review this page or see the review queue and roster.

Model panel commentary is coming to this page: machine commentary, not clinical review.

ProvenanceLast edited 2026-09-18 · Jude Gomila · Link cancer subtypes to their siblings and name parents i… · diff · file

Wikipedia

Neuroendocrine tumor

Sources & links

RADIANT-4 (Lancet 2016)
CABINET (NEJM 2024)
Wikipedia

subtype-page endocrine lung

Data

JSON · ·

Follow this page

Wrong or missing?

Propose a change with a source. Organisations can update their own records. Every suggestion is reviewed, safety-checked and validated before it goes live; nothing is edited directly.

Suggest an editDiscuss start a thread

Out of date?
How review works

Machine-readable versions of Lung neuroendocrine tumours (typical and atypical carcinoid)

JSON record with neighbours
Markdown context for language models
RDF Turtle for this record (its triples, relations and owl:sameAs; the IRI of this record is https://onco.cc/cancers/lung-net/)
Section plan: the ten sections of this record with routes, anchors and counts
All cancers as JSON
RDF N-Triples for the whole corpus
Search index: id, kind, name, TL;DR and route for every record
OpenAPI 3.1 description
API root and meta.json
llms.txt

MCP server: npx -y onco-mcp, tools search, get_entity, list_kind, ask, context, compare. This record is get_entity or context with id lung-net.

WebMCP tools registered on this page: onco_search, onco_get_entity.